Pharmacyclics files for OK of cancer drug
Pharmacyclics said Friday it submitted a new drug application with the U.S. Food and Drug Administration for Xcytrin.The company is seeking an indication for treatment of patients with non-small cell lung cancer that has metastasized to the brain.
This entry was posted on Friday, December 22nd, 2006 at 11:39 am and is filed under Research, Non-Small-Cell, Treatment. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.